BR112021014909A2 - Agitadores tipo vórtex e métodos associados, sistemas e aparelhos destes - Google Patents

Agitadores tipo vórtex e métodos associados, sistemas e aparelhos destes

Info

Publication number
BR112021014909A2
BR112021014909A2 BR112021014909A BR112021014909A BR112021014909A2 BR 112021014909 A2 BR112021014909 A2 BR 112021014909A2 BR 112021014909 A BR112021014909 A BR 112021014909A BR 112021014909 A BR112021014909 A BR 112021014909A BR 112021014909 A2 BR112021014909 A2 BR 112021014909A2
Authority
BR
Brazil
Prior art keywords
wall
vortex
mixing chamber
systems
associated methods
Prior art date
Application number
BR112021014909A
Other languages
English (en)
Inventor
Benjamin Geldhof
Brie Skinner
Kaelyn Vik
Stephanie Kirby
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of BR112021014909A2 publication Critical patent/BR112021014909A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10—Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • B01F25/104—Mixing by creating a vortex flow, e.g. by tangential introduction of flow components characterised by the arrangement of the discharge opening
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10—Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/20—Mixing the contents of independent containers, e.g. test tubes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30—Micromixers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/813—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles mixing simultaneously in two or more mixing receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)

Abstract

agitadores tipo vórtex e métodos associados, sistemas e aparelhos destes. a presente invenção refere-se a um agitador tipo vórtex (vórtice) (400) podendo ter uma câmara de mistura em vórtice (450) tendo uma primeira parede (451), uma segunda parede (452) e uma parede lateral (453) conectando a primeira parede e a segunda parede. pelo menos duas portas de entrada (405, 410, 415, 520) podem ser configuradas ao longo da parede lateral, cada porta de entrada tendo um canal de entrada conectado à mesma. pelo menos duas portas de entrada podem ser aproximadamente igualmente espaçadas em torno da câmara de mistura em vórtice e configuradas tangencialmente à câmara de mistura em vórtice. uma porta de saída (455) pode ter um canal de saída conectado à mesma. a porta de saída pode ser configurada em um centro radial da segunda parede e o canal de saída pode se estender a partir da porta de saída e para longe da câmara de mistura em vórtice.
BR112021014909A 2019-01-31 2020-01-31 Agitadores tipo vórtex e métodos associados, sistemas e aparelhos destes BR112021014909A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962799636P 2019-01-31 2019-01-31
US201962886592P 2019-08-14 2019-08-14
PCT/US2020/016150 WO2020160430A1 (en) 2019-01-31 2020-01-31 Vortex mixers and associated methods, systems, and apparatuses thereof

Publications (1)

Publication Number Publication Date
BR112021014909A2 true BR112021014909A2 (pt) 2021-11-23

Family

ID=69740760

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021014909A BR112021014909A2 (pt) 2019-01-31 2020-01-31 Agitadores tipo vórtex e métodos associados, sistemas e aparelhos destes

Country Status (12)

Country Link
US (1) US20220126244A1 (pt)
EP (1) EP3917656A1 (pt)
JP (1) JP2022523117A (pt)
KR (1) KR20210133218A (pt)
CN (1) CN113710353A (pt)
AU (1) AU2020214425A1 (pt)
BR (1) BR112021014909A2 (pt)
CA (1) CA3128488A1 (pt)
IL (1) IL285214A (pt)
MX (1) MX2021009236A (pt)
SG (1) SG11202108098QA (pt)
WO (1) WO2020160430A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102340408B1 (ko) * 2020-08-05 2021-12-16 건국대학교 산학협력단 용기 고정 장치
CN113908744A (zh) * 2021-11-08 2022-01-11 常州大学 一种微流控混合器及其应用
WO2023193002A1 (en) * 2022-04-01 2023-10-05 Modernatx, Inc. Cross mixers for lipid nanoparticle production, and methods of operating the same
WO2024091918A2 (en) * 2022-10-25 2024-05-02 Modernatx, Inc. Methods of lipid nanoparticle production in cross-mixers
JP7457193B1 (ja) 2023-08-18 2024-03-27 旭有機材株式会社 渦流式流体混合器
JP7457194B1 (ja) 2023-08-18 2024-03-27 旭有機材株式会社 渦流式流体混合器

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405497A (en) * 1990-08-28 1995-04-11 Kamyr, Inc. Method of chemically reacting a liquid with a gas in a vortex
GB9320455D0 (en) * 1993-10-05 1993-11-24 Atomic Energy Authority Uk Vortex mixer
AU744755B2 (en) 1997-11-12 2002-03-07 Brigham And Women's Hospital The translation enhancer element of the human amyloid precursor protein gene
AU3120601A (en) 2000-01-28 2001-08-07 Scripps Research Inst Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
US7468275B2 (en) 2000-01-28 2008-12-23 The Scripps Research Institute Synthetic internal ribosome entry sites and methods of identifying same
EP1800697B1 (de) 2001-06-05 2010-04-14 CureVac GmbH Stabilisierte mRNA mit erhöhtem G/C-Gehalt für die Gentherapie
DE10162480A1 (de) 2001-12-19 2003-08-07 Ingmar Hoerr Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
DE10229872A1 (de) 2002-07-03 2004-01-29 Curevac Gmbh Immunstimulation durch chemisch modifizierte RNA
DE10335833A1 (de) 2003-08-05 2005-03-03 Curevac Gmbh Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
DE102004042546A1 (de) 2004-09-02 2006-03-09 Curevac Gmbh Kombinationstherapie zur Immunstimulation
DE102005023170A1 (de) 2005-05-19 2006-11-23 Curevac Gmbh Optimierte Formulierung für mRNA
EP2479254A1 (en) 2005-08-24 2012-07-25 The Scripps Research Institute Translation enhancer-element dependent vector systems
DE102006007433A1 (de) 2006-02-17 2007-08-23 Curevac Gmbh Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure
CA2659301A1 (en) 2006-07-28 2008-02-07 Applera Corporation Dinucleotide mrna cap analogs
AU2007280690C1 (en) 2006-07-31 2012-08-23 Curevac Gmbh Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant
JP5030520B2 (ja) * 2006-09-29 2012-09-19 富士フイルム株式会社 流体混合方法及びマイクロデバイス
DE102006051516A1 (de) 2006-10-31 2008-05-08 Curevac Gmbh (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
DE102006061015A1 (de) 2006-12-22 2008-06-26 Curevac Gmbh Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
DE102007001370A1 (de) 2007-01-09 2008-07-10 Curevac Gmbh RNA-kodierte Antikörper
WO2008127688A1 (en) 2007-04-13 2008-10-23 Hart Communication Foundation Synchronizing timeslots in a wireless communication protocol
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
JP5474816B2 (ja) 2007-12-11 2014-04-16 ザ スクリプス リサーチ インスティテュート ｍＲＮＡ翻訳エンハンサーエレメントに関する組成物および方法
EP3346005A1 (en) 2008-01-31 2018-07-11 CureVac AG Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
DE102008009199A1 (de) * 2008-02-15 2009-08-27 Forschungszentrum Karlsruhe Gmbh Reaktionsmischersystem zur Vermischung und chemischer Reaktion von mindestens zwei Fluiden
WO2009127230A1 (en) 2008-04-16 2009-10-22 Curevac Gmbh MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
JP4798174B2 (ja) * 2008-05-21 2011-10-19 株式会社日立プラントテクノロジー 乳化装置
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
WO2010088927A1 (en) 2009-02-09 2010-08-12 Curevac Gmbh Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
EA028860B1 (ru) 2009-06-10 2018-01-31 Арбутус Биофарма Корпорэйшн Улучшенная липидная композиция
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
WO2011069529A1 (en) 2009-12-09 2011-06-16 Curevac Gmbh Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
EP2387999A1 (en) 2010-05-21 2011-11-23 CureVac GmbH Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
WO2012009644A2 (en) 2010-07-16 2012-01-19 Arizona Board Of Regents Methods to identify synthetic and natural rna elements that enhance protein translation
CA2801523C (en) 2010-07-30 2021-08-03 Curevac Gmbh Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
WO2012019630A1 (en) 2010-08-13 2012-02-16 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
WO2012089225A1 (en) 2010-12-29 2012-07-05 Curevac Gmbh Combination of vaccination and inhibition of mhc class i restricted antigen presentation
AU2012207606B2 (en) 2011-01-11 2017-02-23 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
WO2012116715A1 (en) 2011-03-02 2012-09-07 Curevac Gmbh Vaccination in newborns and infants
WO2012113413A1 (en) 2011-02-21 2012-08-30 Curevac Gmbh Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
WO2012116714A1 (en) 2011-03-02 2012-09-07 Curevac Gmbh Vaccination in elderly patients
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
WO2013113325A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Negatively charged nucleic acid comprising complexes for immunostimulation
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
EP2623121A1 (en) 2012-01-31 2013-08-07 Bayer Innovation GmbH Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
WO2013120497A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
WO2013120500A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
WO2013120498A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
WO2013120499A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
BR112014023898A2 (pt) 2012-03-27 2017-07-11 Curevac Gmbh moléculas de ácido nucleico artificiais compreendendo 5''utr top
AU2013242404B2 (en) 2012-03-27 2018-08-30 CureVac SE Artificial nucleic acid molecules for improved protein or peptide expression
KR102186497B1 (ko) 2012-03-27 2020-12-04 큐어백 아게 인공 핵산 분자
EP3498267A1 (en) 2012-05-25 2019-06-19 CureVac AG Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
US9974845B2 (en) 2013-02-22 2018-05-22 Curevac Ag Combination of vaccination and inhibition of the PD-1 pathway
WO2015002667A1 (en) 2013-07-01 2015-01-08 Myq, Inc. A location regulated point-of-sale system and enhancements
CA2915730A1 (en) 2013-08-21 2015-02-26 Karl-Josef Kallen A combination rsv/influenza a vaccine
SG11201510747RA (en) 2013-08-21 2016-03-30 Curevac Ag Method for increasing expression of rna-encoded proteins
SG11201510746WA (en) 2013-08-21 2016-03-30 Curevac Ag Respiratory syncytial virus (rsv) vaccine
CN105517569A (zh) 2013-08-21 2016-04-20 库瑞瓦格股份公司 狂犬病疫苗
HUE046469T2 (hu) 2013-08-21 2020-03-30 Curevac Ag Készítmény és vakcina tüdõrák kezelésére
WO2015024664A1 (en) 2013-08-21 2015-02-26 Curevac Gmbh Composition and vaccine for treating prostate cancer
CA2925021A1 (en) 2013-11-01 2015-05-07 Curevac Ag Modified rna with decreased immunostimulatory properties
CA2927254C (en) 2013-12-30 2023-10-24 Curevac Ag Artificial nucleic acid molecules
WO2015101416A1 (en) 2013-12-30 2015-07-09 Curevac Gmbh Methods for rna analysis
BR112016014462A2 (pt) 2013-12-30 2017-10-24 Curevac Ag moléculas de ácido nucleico artificiais
EP3556353A3 (en) 2014-02-25 2020-03-18 Merck Sharp & Dohme Corp. Lipid nanoparticle vaccine adjuvants and antigen delivery systems
CA2983804C (en) * 2015-04-28 2021-08-17 The University Of British Columbia Disposable microfluidic cartridge
JP6925020B2 (ja) * 2017-03-22 2021-08-25 国立大学法人横浜国立大学 混合装置及び混合方法

Also Published As

Publication number Publication date
EP3917656A1 (en) 2021-12-08
JP2022523117A (ja) 2022-04-21
MX2021009236A (es) 2021-11-12
CA3128488A1 (en) 2020-08-06
AU2020214425A1 (en) 2021-08-19
CN113710353A (zh) 2021-11-26
IL285214A (en) 2021-09-30
US20220126244A1 (en) 2022-04-28
WO2020160430A1 (en) 2020-08-06
KR20210133218A (ko) 2021-11-05
SG11202108098QA (en) 2021-08-30

Similar Documents

Publication Publication Date Title
BR112021014909A2 (pt) Agitadores tipo vórtex e métodos associados, sistemas e aparelhos destes
ATE364438T1 (de) Statischer mikrovermischer
DE502005003443D1 (de) Statischer Mikrovermischer
RU2010114215A (ru) Динамический смеситель
DK0708681T3 (da) Apparat til blanding af komponenter i en fluidstrøm
BR112017015329A2 (pt) sistema de medição para particulado sólido.
EP2944763A3 (en) Hot gas path component
BR112015009408A2 (pt) cabeça de aspersão para misturador de dois componentes
MY187985A (en) A stormwater filter
DE502007000238D1 (de) Milchaufschäumvorrichtung
CO2020006470A2 (es) Ensamble de flujo transversal y método para producción de gotas pequeñas controladas por emulsificación de membrana
BR112018000935A2 (pt) ?sistema microfluídico, recipiente, e, método?
BR112016025253A2 (pt) misturador estático
HRP20211809T1 (hr) Difuzor zraka
KR101479796B1 (ko) 인라인 믹서 장치
BR112018002859A2 (pt) Receptor solar
BR112018006304A2 (pt) aparelho misturador de pós, e método de misturar um pó
EA201790846A1 (ru) Набор из двух или более реакторов и реактор, используемый в таком наборе
US3794056A (en) Fluidic pulse and flow divider
BR112021012943A2 (pt) Corpo de sonda, sonda óptica, uso do corpo da sonda, e, método
KR101599059B1 (ko) 폐 액형 재료를 줄일 수 있는 이액형 믹싱팁
MY193271A (en) Impeller for centrifugal pumps
EP3167954A1 (en) Static mixer
BR112017020475A2 (pt) ?dispositivo para reduzir o ruído de jato de um motor de turbina, e, motor de turbina?
WO2019005693A9 (en) FOOD DEPILER CUT

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements